Sleep Duration in Women With Previous Gestational Diabetes



Status:Not yet recruiting
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 45
Updated:8/23/2018
Start Date:November 1, 2018
End Date:January 1, 2021
Contact:Sirimon Reutrakul
Email:sreutrak@uic.edu
Phone:3124135357

Use our guide to learn which trials are right for you!

The Effect of Sleep Extension on Glucose Metabolism in Women With Previous Diagnosis of Gestational Diabetes

Women with a history of gestational diabetes (GDM) are at high risk of developing diabetes in
the future. Sleep disturbances are emerging as risk factors for incident diabetes. The
purpose of this study is to test the effects of 6-week sleep extension in women with a
history of GDM and short sleep on glucose metabolism by randomized controlled study.

The primary aim of this study is to evaluate the effects of a sleep extension intervention in
non-diabetic women with a prior history of GDM and habitual short sleep duration on the
outcomes of glucose metabolism. The participants will be randomized to a 6-week sleep
extension intervention group, using technology-assisted sleep intervention, or a healthy
living information control group. Glucose metabolism parameters will be assessed by an oral
glucose tolerant test.

Inclusion Criteria:

- Premenopausal women, age 18-45, with a history of GDM who currently do not have
diabetes

- At least one year post-partum

- Reported habitual sleep duration <6.5h/night during work- or weekdays with a desire to
sleep longer

- Own a smartphone compatible with Fitbit.

- No need to provide care at night for her child(ren)

- No history of obstructive sleep apnea, insomnia, or restless leg syndrome

Exclusion Criteria:

- A1C ≥6.5%

- Currently pregnant or planning pregnancy or breast feeding

- Insomnia symptoms defined as severe as assessed by the Insomnia Severity Index (score
≥22)

- Rotating shift or night shift work

- High risk for obstructive sleep apnea screened by STOP BANG questionnaire.

- Significant medical morbidities, such as congestive heart failure, cirrhosis, chronic
obstructive pulmonary disease requiring oxygen, active treatment for cancer or
psychiatric problem, history of stroke with neurological deficits, cognitive
impairment, kidney failure requiring dialysis, illicit drug use.
We found this trial at
1
site
2035 W Taylor St
Chicago, Illinois
(312) 996-4350
University of Illinois at Chicago A major research university in the heart of one of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials